AiPing Pharmaceutical Inc. Email Format
Pharmaceutical ManufacturingNew York, United States2-10 Employees
AiPing Pharmaceutical, Inc. is a U.S.-based manufacturer of generic medicines with an international footprint, handling the full lifecycle of product development—from sourcing and redevelopment to commercial launch. The company emphasizes quality processes and customer service while offering a broad portfolio of generic prescription and OTC products in solid oral dosage forms. Its portfolio includes tablets, capsules, and soft gels. Headquartered in Hauppauge, New York, AiPing operates as a small team with global reach. Public records indicate that AiPing sold assets to Shandong Xinhua Pharma in 2018. Shandong Xinhua Pharma later acquired three U.S. ibuprofen Abbreviated New Drug Applications, and granted AiPing distribution rights in the United States.